Company
Biontech Ag
9 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 18044955 | AGENTS AND METHODS FOR TARGETED DELIVERY TO CELLS | A61K, C12N, A61P, C07K | Sep 13, 2021 | |
| 18007096 | RAS NEOANTIGENS AND USES THEREOF | A61K, C07K, A61P, C12N | Aug 11, 2021 | |
| 18007024 | T CELL MANUFACTURING COMPOSITIONS AND METHODS | C12N, A61K | Aug 11, 2021 | |
| 17360437 | Multispecific antibodies against CD40 and CD137 | G01N, C07K, A61K | Jun 27, 2021 | Mar 25, 2024 |
| 17360438 | MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137 | C07K, G01N, A61K | Jun 27, 2021 | |
| 18007550 | RNA Replicon for Versatile and Efficient Gene Expression | C12N | May 31, 2021 | |
| 17330342 | Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell | A61P, A61K | May 24, 2021 | May 23, 2022 |
| 17245605 | Therapeutic RNA | A61P, A61K | Apr 29, 2021 | Jan 8, 2024 |
| 17241651 | USE OF RNA FOR REPROGRAMMING SOMATIC CELLS | C12N | Apr 26, 2021 | |
| 17233396 | Coronavirus vaccine | A61K, A61P, C12N | Apr 15, 2021 | Jan 9, 2023 |
| 17915567 | RNA COMPOSITIONS TARGETING CLAUDIN-18.2 | C07K, A61P | Mar 28, 2021 | |
| 17209926 | CYTOTOXIC IMMUNOSTIMULATING PARTICLES AND USES THEREOF | A61K | Mar 22, 2021 | |
| 17912841 | CORONAVIRUS VACCINES AND METHODS OF USE | A61P, A61K | Mar 18, 2021 | |
| 17904937 | COMPOSITE RNA PARTICLES | C12N, A61K | Feb 25, 2021 | |
| 17170826 | PREPARATION AND STORAGE OF LIPOSOMAL RNA FORMULATIONS SUITABLE FOR THERAPY | A61K | Feb 7, 2021 | |
| 17759906 | TREATMENT INVOLVING ANTIGEN VACCINATION AND BINDING AGENTS BINDING TO PD-L1 AND CD137 | C07K, A61P, A61K | Feb 1, 2021 | |
| 17144591 | Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (CD137) | C07K | Jan 7, 2021 | Nov 13, 2023 |
| 17131713 | Human monoclonal antibodies to ganglioside GD2 | G01N, A61K, C07K | Dec 21, 2020 | Sep 18, 2023 |
| 17777977 | Prame TCR Receptors And Uses Thereof | G01N, C07K, A61P, A61K | Nov 17, 2020 | |
| 17012599 | Method for reducing immunogenicity of RNA | C12N, C07K, C12P | Sep 3, 2020 | Jan 15, 2024 |